- Home
- OTTR vs VKTX Comparison
OTTR vs VKTX Comparison
Compare OTTR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTTR | VKTX |
|---|---|---|
| Founded | 1907 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OTTR | VKTX |
|---|---|---|
| Price | $90.72 | $32.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $95.86 |
| AVG Volume (30 Days) | 208.1K | ★ 1.7M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $1,299,640,000.00 | N/A |
| Revenue This Year | $1.99 | N/A |
| Revenue Next Year | $3.83 | N/A |
| P/E Ratio | $59.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $74.15 | $22.96 |
| 52 Week High | $95.09 | $43.15 |
Technical Indicators
Market Signals| Indicator | OTTR | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.29 | 43.81 |
| Support Level | $84.46 | $31.88 |
| Resistance Level | $92.42 | $32.92 |
| Average True Range (ATR) | 1.59 | 1.33 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 39.24 | 13.64 |
Price Performance
Historical ComparisonAbout OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.